Anti-Aging Products and Therapies
Anti-Aging Products and Therapies market is segmented by company, region (country), by Type, and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biodefense Market Size Growth Rate by Type (2021-2027) 1.2.2 Anthrax 1.2.3 Smallpox 1.2.4 Botulism 1.2.5 Radiation/Nuclear 1.2.6 Others 1.3 Market by Application 1.3.1 Global Biodefense Market Share by Application (2021-2027) 1.3.2 US Military Market 1.3.3 US Civilian Market 1.3.4 Non - US Market 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Biodefense Market Size 2.2 Biodefense Market Size by Regions 2.2.1 Biodefense Growth Rate by Regions (2021-2027) 2.2.2 Biodefense Market Share by Regions (2021-2027) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 Biodefense Revenue by Players (2020-2021) 3.2 Biodefense Key Players Headquaters and Area Served 3.3 Key Players Biodefense Product/Solution/Service 3.4 Date of Enter into Biodefense Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global Biodefense Market Size by Type (2021-2027) 4.2 Global Biodefense Market Size by Application (2021-2027) 5 North America 5.1 North America Biodefense Market Forecast (2021-2027) 5.2 Biodefense Key Players in North America 5.3 North America Biodefense Market Size by Type 5.4 North America Biodefense Market Size by Application 6.4.4 Canada 6 Europe 6.1 Europe Biodefense Market Forecast (2021-2027) 6.2 Biodefense Key Players in Europe 6.3 Europe Biodefense Market Size by Type 6.4 Europe Biodefense Market Size by Application 7 Japan 7.1 Japan Biodefense Market Forecast (2021-2027) 7.2 Biodefense Key Players in Europe 7.3 Japan Biodefense Market Size by Type 7.4 Japan Biodefense Market Size by Application 8 Rest of World 8.1 China 8.1.1 China Biodefense Market Analysis 8.1.2 Key Players in China 8.2 Southeast Asia 8.2.1 Southeast Asia Biodefense Market Analysis 8.2.2 Key Players in Southeast Asia 8.3 India 8.3.1 India Biodefense Market Analysis 8.3.2 Key Players in India 9 International Player Profiles 9.1 Emergent Biosolutions 9.1.1 Emergent Biosolutions Company Details 9.1.2 Emergent Biosolutions Description and Business Overview 9.1.3 Emergent Biosolutions Biodefense Introduction 9.1.4 Emergent Biosolutions Revenue in Biodefense Business (2020-2021) 9.1.5 Emergent Biosolutions Recent Development 9.2 Hytest 9.2.1 Hytest Company Details 9.2.2 Hytest Description and Business Overview 9.2.3 Hytest Biodefense Introduction 9.2.4 Hytest Revenue in Biodefense Business (2020-2021) 9.2.5 Hytest Recent Development 9.3 GSK 9.3.1 GSK Company Details 9.3.2 GSK Description and Business Overview 9.3.3 GSK Biodefense Introduction 9.3.4 GSK Revenue in Biodefense Business (2020-2021) 9.3.5 GSK Recent Development 9.4 Sanofi 9.4.1 Sanofi Company Details 9.4.2 Sanofi Description and Business Overview 9.4.3 Sanofi Biodefense Introduction 9.4.4 Sanofi Revenue in Biodefense Business (2020-2021) 9.4.5 Sanofi Recent Development 9.5 PharmAthene 9.5.1 PharmAthene Company Details 9.5.2 PharmAthene Description and Business Overview 9.5.3 PharmAthene Biodefense Introduction 9.5.4 PharmAthene Revenue in Biodefense Business (2020-2021) 9.5.5 PharmAthene Recent Development 9.6 Bavarian Nordic 9.6.1 Bavarian Nordic Company Details 9.6.2 Bavarian Nordic Description and Business Overview 9.6.3 Bavarian Nordic Biodefense Introduction 9.6.4 Bavarian Nordic Revenue in Biodefense Business (2020-2021) 9.6.5 Bavarian Nordic Recent Development 9.7 SIGA Technologies 9.7.1 SIGA Technologies Company Details 9.7.2 SIGA Technologies Description and Business Overview 9.7.3 SIGA Technologies Biodefense Introduction 9.7.4 SIGA Technologies Revenue in Biodefense Business (2020-2021) 9.7.5 SIGA Technologies Recent Development 9.8 Arbutus Biopharma 9.8.1 Arbutus Biopharma Company Details 9.8.2 Arbutus Biopharma Description and Business Overview 9.8.3 Arbutus Biopharma Biodefense Introduction 9.8.4 Arbutus Biopharma Revenue in Biodefense Business (2020-2021) 9.8.5 Arbutus Biopharma Recent Development 9.9 DynPort Vaccine 9.9.1 DynPort Vaccine Company Details 9.9.2 DynPort Vaccine Description and Business Overview 9.9.3 DynPort Vaccine Biodefense Introduction 9.9.4 DynPort Vaccine Revenue in Biodefense Business (2020-2021) 9.9.5 DynPort Vaccine Recent Development 9.10 Xoma Corporation 9.10.1 Xoma Corporation Company Details 9.10.2 Xoma Corporation Description and Business Overview 9.10.3 Xoma Corporation Biodefense Introduction 9.10.4 Xoma Corporation Revenue in Biodefense Business (2020-2021) 9.10.5 Xoma Corporation Recent Development 9.11 Ichor Medical Systems 9.11.1 Ichor Medical Systems Company Details 9.11.2 Ichor Medical Systems Description and Business Overview 9.11.3 Ichor Medical Systems Biodefense Introduction 9.11.4 Ichor Medical Systems Revenue in Biodefense Business (2020-2021) 9.11.5 Ichor Medical Systems Recent Development 9.12 Aeolus Pharmaceuticals 9.12.1 Aeolus Pharmaceuticals Company Details 9.12.2 Aeolus Pharmaceuticals Description and Business Overview 9.12.3 Aeolus Pharmaceuticals Biodefense Introduction 9.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2020-2021) 9.12.5 Aeolus Pharmaceuticals Recent Development 9.13 Achaogen 9.13.1 Achaogen Company Details 9.13.2 Achaogen Description and Business Overview 9.13.3 Achaogen Biodefense Introduction 9.13.4 Achaogen Revenue in Biodefense Business (2020-2021) 9.13.5 Achaogen Recent Development 9.14 Elusys Therapeutics 9.14.1 Elusys Therapeutics Company Details 9.14.2 Elusys Therapeutics Description and Business Overview 9.14.3 Elusys Therapeutics Biodefense Introduction 9.14.4 Elusys Therapeutics Revenue in Biodefense Business (2020-2021) 9.14.5 Elusys Therapeutics Recent Development 9.15 Dynavax Technologies 9.15.1 Dynavax Technologies Company Details 9.15.2 Dynavax Technologies Description and Business Overview 9.15.3 Dynavax Technologies Biodefense Introduction 9.15.4 Dynavax Technologies Revenue in Biodefense Business (2020-2021) 9.15.5 Dynavax Technologies Recent Development 9.16 Cleveland BioLabs 9.16.1 Company Details 9.16.2 Cleveland BioLabs Description and Business Overview 9.16.3 Cleveland BioLabs Biodefense Introduction 9.16.4 Cleveland BioLabs Revenue in Biodefense Business (2020-2021) 9.16.5 Cleveland BioLabs Recent Development 9.17 Soligenix 9.17.1 Soligenix Company Details 9.17.2 Soligenix Description and Business Overview 9.17.3 Soligenix Biodefense Introduction 9.17.4 Soligenix Revenue in Biodefense Business (2020-2021) 9.17.5 Soligenix Recent Development 9.18 Alnylam Pharmaceuticals 9.18.1 Alnylam Pharmaceuticals Company Details 9.18.2 Alnylam Pharmaceuticals Description and Business Overview 9.18.3 Alnylam Pharmaceuticals Biodefense Introduction 9.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2020-2021) 9.18.5 Alnylam Pharmaceuticals Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details
List of Tables Table 1. Global Biodefense Market Size Growth Rate by Type (2021-2027) (US$ Million) Table 2. Key Players of Anthrax Table 3. Key Players of Smallpox Table 4. Key Players of Botulism Table 5. Key Players of Radiation/Nuclear Table 6. Key Players of Others Table 7. Global Biodefense Market Size Growth by Application (2021-2027) (US$ Million) Table 8. Global Biodefense Market Size by Regions (2021-2027) (US$ Million) Table 9. Global Biodefense Market Share by Regions (2021-2027) Table 10. Market Top Trends Table 11. Market Use Cases Table 12. Global Biodefense Revenue by Players (2020-2021) (US$ Million) Table 13. Global Biodefense Market Share by Players (2020-2021) Table 14. Key Players Headquarters and Area Served Table 15. Key Players Biodefense Product Solution and Service Table 16. Date of Enter into Biodefense Market Table 17. Mergers & Acquisitions, Expansion Plans Table 18. Global Biodefense Market Size by Type (2021-2027) (US$ Million) Table 19. Global Biodefense Market Size Share by Type (2021-2027) Table 20. Global Biodefense Market Size by Application (2021-2027) (US$ Million) Table 21. Global Biodefense Market Size Share by Application (2021-2027) Table 22. North America Key Players Biodefense Revenue (2020-2021) (US$ Million) Table 23. North America Key Players Biodefense Market Share (2020-2021) Table 24. North America Biodefense Market Size by Type (2021-2027) (US$ Million) Table 25. North America Biodefense Market Share by Type (2021-2027) Table 26. North America Biodefense Market Size by Application (2021-2027) (US$ Million) Table 27. North America Biodefense Market Share by Application (2021-2027) Table 28. Europe Key Players Biodefense Revenue (2020-2021) (US$ Million) Table 29. Europe Key Players Biodefense Market Share (2020-2021) Table 30. Europe Biodefense Market Size by Type (2021-2027) (US$ Million) Table 31. Europe Biodefense Market Share by Type (2021-2027) Table 32. Europe Biodefense Market Size by Application (2021-2027) (US$ Million) Table 33. Europe Biodefense Market Share by Application (2021-2027) Table 34. Japan Key Players Biodefense Revenue (2020-2021) (US$ Million) Table 35. Japan Key Players Biodefense Market Share (2020-2021) Table 36. Japan Biodefense Market Size by Type (2021-2027) (US$ Million) Table 37. Japan Biodefense Market Share by Type (2021-2027) Table 38. Japan Biodefense Market Size by Application (2021-2027) (US$ Million) Table 39. Japan Biodefense Market Share by Application (2021-2027) Table 40. Key Players in China Table 41. Key Players in Southeast Asia Table 42. Key Players in India Table 43. Emergent Biosolutions Company Details Table 44. Emergent Biosolutions Description and Business Overview Table 45. Emergent Biosolutions Biodefense Product Table 46. Emergent Biosolutions Revenue in Biodefense Business 2020 and 2021 Table 47. Emergent Biosolutions Recent Development Table 48. Hytest Company Details Table 49. Hytest Description and Business Overview Table 50. Hytest Biodefense Product Table 51. Hytest Revenue in Biodefense Business 2020 and 2021 Table 52. Hytest Recent Development Table 53. GSK Company Details Table 54. GSK Description and Business Overview Table 55. GSK Biodefense Product Table 56. GSK Revenue in Biodefense Business 2020 and 2021 Table 57. GSK Recent Development Table 58. Sanofi Company Details Table 59. Sanofi Description and Business Overview Table 60. Sanofi Biodefense Product Table 61. Sanofi Revenue in Biodefense Business 2020 and 2021 Table 62. Sanofi Recent Development Table 63. PharmAthene Company Details Table 64. PharmAthene Description and Business Overview Table 65. PharmAthene Biodefense Product Table 66. PharmAthene Revenue in Biodefense Business 2020 and 2021 Table 67. PharmAthene Recent Development Table 68. Bavarian Nordic Company Details Table 69. Bavarian Nordic Description and Business Overview Table 70. Bavarian Nordic Biodefense Product Table 71. Bavarian Nordic Revenue in Biodefense Business 2020 and 2021 Table 72. Bavarian Nordic Recent Development Table 73. SIGA Technologies Company Details Table 74. SIGA Technologies Description and Business Overview Table 75. SIGA Technologies Biodefense Product Table 76. SIGA Technologies Revenue in Biodefense Business 2020 and 2021 Table 77. SIGA Technologies Recent Development Table 78. Arbutus Biopharma Company Details Table 79. Arbutus Biopharma Description and Business Overview Table 80. Arbutus Biopharma Biodefense Product Table 81. Arbutus Biopharma Revenue in Biodefense Business 2020 and 2021 Table 82. Arbutus Biopharma Recent Development Table 83. DynPort Vaccine Company Details Table 84. DynPort Vaccine Description and Business Overview Table 85. DynPort Vaccine Biodefense Product Table 86. DynPort Vaccine Revenue in Biodefense Business 2020 and 2021 Table 87. DynPort Vaccine Recent Development Table 88. Xoma Corporation Company Details Table 89. Xoma Corporation Description and Business Overview Table 90. Xoma Corporation Biodefense Product Table 91. Xoma Corporation Revenue in Biodefense Business 2020 and 2021 Table 92. Xoma Corporation Recent Development Table 93. Ichor Medical Systems Company Details Table 94. Ichor Medical Systems Description and Business Overview Table 95. Ichor Medical Systems Biodefense Product Table 96. Ichor Medical Systems Revenue in Biodefense Business 2020 and 2021 Table 97. Ichor Medical Systems Recent Development Table 98. Aeolus Pharmaceuticals Company Details Table 99. Aeolus Pharmaceuticals Description and Business Overview Table 100. Aeolus Pharmaceuticals Biodefense Product Table 101. Aeolus Pharmaceuticals Revenue in Biodefense Business 2020 and 2021 Table 102. Aeolus Pharmaceuticals Recent Development Table 103. Achaogen Company Details Table 104. Achaogen Description and Business Overview Table 105. Achaogen Biodefense Product Table 106. Achaogen Revenue in Biodefense Business 2020 and 2021 Table 107. Achaogen Recent Development Table 108. Elusys Therapeutics Company Details Table 109. Elusys Therapeutics Description and Business Overview Table 110. Elusys Therapeutics Biodefense Product Table 111. Elusys Therapeutics Revenue in Biodefense Business 2020 and 2021 Table 112. Elusys Therapeutics Recent Development Table 113. Dynavax Technologies Company Details Table 114. Dynavax Technologies Description and Business Overview Table 115. Dynavax Technologies Biodefense Product Table 116. Dynavax Technologies Revenue in Biodefense Business 2020 and 2021 Table 117. Dynavax Technologies Recent Development Table 118. Cleveland BioLabs Company Details Table 119. Cleveland BioLabs Description and Business Overview Table 120. Cleveland BioLabs Biodefense Product Table 121. Cleveland BioLabs Revenue in Biodefense Business 2020 and 2021 Table 122. Cleveland BioLabs Recent Development Table 123. Soligenix Company Details Table 124. Soligenix Description and Business Overview Table 125. Soligenix Biodefense Product Table 126. Soligenix Revenue in Biodefense Business 2020 and 2021 Table 127. Soligenix Recent Development Table 128. Alnylam Pharmaceuticals Company Details Table 129. Alnylam Pharmaceuticals Description and Business Overview Table 130. Alnylam Pharmaceuticals Biodefense Product Table 131. Alnylam Pharmaceuticals Revenue in Biodefense Business 2020 and 2021 Table 132. Alnylam Pharmaceuticals Recent Development Table 133. Biodefense Market Trends Table 134. Biodefense Market Drivers Table 135. Biodefense Market Challenges Table 136. Biodefense Market Restraints Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Global Biodefense Market Share by Type in 2021 & 2027 Figure 2. Anthrax Features Figure 3. Smallpox Features Figure 4. Botulism Features Figure 5. Radiation/Nuclear Features Figure 6. Others Features Figure 7. Global Biodefense Market Share by Application in 2021 & 2027 Figure 8. US Military Market Case Studies Figure 9. US Civilian Market Case Studies Figure 10. Non - US Market Case Studies Figure 11. Biodefense Report Years Considered Figure 12. Global Biodefense Market Size and Growth Rate (2020-2027) (US$ Million) Figure 13. Global Biodefense Market Share by Regions (2020-2027) Figure 14. Global Biodefense Market Share by Players in 2021 Figure 15. Global Biodefense Market Size Market Share by Type (2021-2027) Figure 16. Global Biodefense Market Size Market Share by Application (2021-2027) Figure 17. Global Biodefense Revenue Market Share by Application in 2021 Figure 18. North America Biodefense Market Size 2021-2027 (US$ Million) Figure 19. Europe Biodefense Market Size 2021-2027 (US$ Million) Figure 20. Japan Biodefense Market Size 2021-2027 (US$ Million) Figure 21. Biodefense Market Size in China (2021-2027) (US$ Million) Figure 22. Biodefense Market Size in Southeast Asia (2021-2027) (US$ Million) Figure 23. Biodefense Market Size in India (2021-2027) (US$ Million) Figure 24. Bottom-up and Top-down Approaches for This Report Figure 25. Data Triangulation Figure 26. Key Executives Interviewed
Emergent Biosolutions Hytest GSK Sanofi PharmAthene Bavarian Nordic SIGA Technologies Arbutus Biopharma DynPort Vaccine Xoma Corporation Ichor Medical Systems Aeolus Pharmaceuticals Achaogen Elusys Therapeutics Dynavax Technologies Cleveland BioLabs Soligenix Alnylam Pharmaceuticals
Anti-Aging Products and Therapies market is segmented by company, region (country), by Type, and ... Read More
Endoscopy Visualization System Components market is segmented by company, region (country), by Ty ... Read More
Automotive Software market is segmented by company, region (country), by Type, and by Application ... Read More
Whole Exome Sequencing market is segmented by company, region (country), by Type, and by Applicat ... Read More